Sigma Planning Corp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,099
Closed -$589K 1342
2022
Q4
$589K Buy
+21,099
New +$539K 0.02% 697
2022
Q3
Sell
-8,445
Closed -$285K 1320
2022
Q2
$285K Buy
+8,445
New +$296K 0.01% 1016
2022
Q1
Sell
-21,141
Closed -$644K 1461
2021
Q4
$644K Buy
+21,141
New +$689K 0.02% 730
2021
Q3
Sell
-10,167
Closed -$308K 1457
2021
Q2
$308K Buy
+10,167
New +$335K 0.01% 1064

Other funds holding OGN

Sigma Planning Corp's OGN Position: Q1 2023 in Review

Sigma Planning Corp sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 21,099 shares — an estimated $589K sold.

Sigma Planning Corp first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $644K in Q4 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Sigma Planning Corp reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 21,099 Organon & Co shares in Q1 2023, an estimated $589K.
  • Sigma Planning Corp first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Sigma Planning Corp's Organon & Co position peaked at $644K in Q4 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Sigma Planning Corp's 13F filing for Q1 2023, filed 8 May 2023.